Get started
Author

Tünde Nagy

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
2022 · C.E. Geyer, J.E. Garber, et al. · Annals of Oncology · 515
PDF
Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3)
2005 · Anne Lespine, Jacques Dupuy, et al. · Chemico-Biological Interactions · 126
Cholesterol Potentiates ABCG2 Activity in a Heterologous Expression System: Improved in Vitro Model to Study Function of Human ABCG2
2007 · Á. Pál, D. Méhn, et al. · Journal of Pharmacology and Experimental Therapeutics · 109
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
2023 · H. Borghaei, F. de Marinis, et al. · Annals of Oncology · 105
PDF
Effect of Membrane Cholesterol on BSEP/Bsep Activity: Species Specificity Studies for Substrates and Inhibitors
2009 · Emese Kis, Enikő Ioja, et al. · Drug Metabolism and Disposition · 94
Membrane Structure Modulation, Protein Kinase Cα Activation, and Anticancer Activity of Minerval
2004 · Jordi Martínez, Oliver Vögler, et al. · Molecular Pharmacology · 79
Leflunomide and its metabolite A771726 are high affinity substrates of BCRP: implications for drug resistance
2008 · E Kis, T Nagy, et al. · Annals of the Rheumatic Diseases · 75
Interaction of Macrocyclic Lactones with the Multidrug Transporters: The Bases of the Pharmacokinetics of Lipid-Like Drugs
2009 · A. Lespine, J. Dupuy, et al. · Current Drug Metabolism · 51
Ivermectin Interacts With Human ABCG2
2010 · Márton Jani, Ildikó Makai, et al. · Journal of Pharmaceutical Sciences · 47
PDF
Receptor-like properties of the 26 kDa transmembrane form of TNF.
2001 · A Domonkos, A Udvardy, et al. · PubMed · 46
Calcein assay: a high-throughput method to assess P-gp inhibition
2011 · H. Glavinas, O. von Richter, et al. · Xenobiotica · 39
Specific inhibition of the ABCG2 transporter could improve the efficacy of photodynamic therapy
2011 · Attila Bebes, Tünde Nagy, et al. · Journal of Photochemistry and Photobiology B Biology · 28
Parvalbumin- and calbindin-containing neurons express c-fos protein in primary and secondary (mirror) epileptic foci of the rat neocortex1Dedicated to the memory of Prof. Ferenc Joo.12The results were presented in preliminary form of a congress abstract at the LXI Cold Spring Harbor Symposium on Quantitative Biology, 29 May–5 June 1996.2
1997 · Andras Mihaly, Magdolna Szente, et al. · Brain Research · 27
Flow cytometric cytotoxicity assay for measuring mammalian and avian NK cell activity
2002 · Csaba Vizler, Tünde Nagy, et al. · Cytometry · 26
The expressions of ABCC4 and ABCG2 xenobiotic transporters in human keratinocytes are proliferation-related
2011 · Attila Bebes, Kornélia Kis, et al. · Archives of Dermatological Research · 22
Impact of SHMT1 polymorphism on the clinical outcome of patients with metastatic colorectal cancer treated with first-line FOLFIRI+bevacizumab
2011 · Barna Budai, Viktor Komlósi, et al. · Pharmacogenetics and Genomics · 21
Mouse Bsep ATPase Assay: A Nonradioactive Tool for Assessment of the Cholestatic Potential of Drugs
2008 · Emese Kis, Zsuzsanna Rajnai, et al. · SLAS DISCOVERY · 18
PDF
Synergistic Effect of Avemar on Proinflammatory Cytokine Production and Ras-Mediated Cell Activation
2005 · ANDRÁS TELEKES, ENDRE KISS-TÓTH, et al. · Annals of the New York Academy of Sciences · 17
Membrane Assays to Characterize Interaction of Drugs with ABCB1
2015 · Zsolt Fekete, Zsuzsanna Rajnai, et al. · The Journal of Membrane Biology · 13
Successful Treatment of Solitary Bone Metastasis of Non-Small Cell Lung Cancer with Bevacizumab and Hyperthermia
2012 · Gábor Rubovszky, Tünde Nagy, et al. · Pathology & Oncology Research · 10
Predictive Value of Early Skin Rash in Cetuximab-Based Therapy of Advanced Biliary Tract Cancer
2017 · Gábor Rubovszky, Barna Budai, et al. · Pathology & Oncology Research · 6
Tumor cells expressing membrane-bound tumor necrosis factor activate macrophages and have a compromised growth in immunosuppressed and immunodeficient mice
2003 · Tünde Nagy, Hristos Glavinas, et al. · Cancer Letters · 6
[Effect of imatinib treatment of gastrointestinal stromal tumors].
2003 · Sándor Eckhardt, Zsuzsanna Pápai, et al. · PubMed · 4
Amethyst NSCLC trial: Phase 2, parallel-arm study of receptor tyrosine kinase (RTK) inhibitor, MGCD265 in patients with advanced or metastatic non-small cell lung cancer (NSCLC) with activating genetic alterations in mesenchymal-epithelial transition factor (MET)
2016 · L. Bazhenova, R. Mehra, et al. · Annals of Oncology · 3
Pathophysiological effects of human TNF‐alpha‐producing tumor xenografts in immunosuppressed mice
1999 · T. Nagy, T. J´nossy, et al. · Apmis · 3
Works count: 44
Citation count: 1,499
H-index: 17
I10-index: 20
Year
Topic
Type